Kensuke Nakazawa

795 total citations
30 papers, 489 citations indexed

About

Kensuke Nakazawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Kensuke Nakazawa has authored 30 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Kensuke Nakazawa's work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). Kensuke Nakazawa is often cited by papers focused on Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). Kensuke Nakazawa collaborates with scholars based in Japan, United States and Australia. Kensuke Nakazawa's co-authors include Nobuyuki Hizawa, Hiroaki Satoh, Koichi Kurishima, Tomohiro Tamura, Hiroichi Ishikawa, Katsunori Kagohashi, Toshihiro Shiozawa, Hiroko Watanabe, Shinya Sato and Ikuo Sekine and has published in prestigious journals such as Journal of Thoracic Oncology, Lung Cancer and Medical Oncology.

In The Last Decade

Kensuke Nakazawa

26 papers receiving 481 citations

Peers

Kensuke Nakazawa
M Paesmans Belgium
Kensuke Nakazawa
Citations per year, relative to Kensuke Nakazawa Kensuke Nakazawa (= 1×) peers M Paesmans

Countries citing papers authored by Kensuke Nakazawa

Since Specialization
Citations

This map shows the geographic impact of Kensuke Nakazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Nakazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Nakazawa more than expected).

Fields of papers citing papers by Kensuke Nakazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensuke Nakazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Nakazawa. The network helps show where Kensuke Nakazawa may publish in the future.

Co-authorship network of co-authors of Kensuke Nakazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kensuke Nakazawa. A scholar is included among the top collaborators of Kensuke Nakazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensuke Nakazawa. Kensuke Nakazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morishima, Yuko, et al.. (2025). Drug-induced autoimmune thyroiditis during lorlatinib treatment in a patient with ALK-positive non-small cell lung cancer. Respiratory Investigation. 63(6). 1306–1308.
2.
Watanabe, Ryo, Kensuke Nakazawa, Naohiro Kobayashi, et al.. (2024). Primary mediastinal choriocarcinoma in a woman treated with VIP therapy instead of BEP therapy for the prevention of postoperative acute respiratory distress syndrome. International Cancer Conference Journal. 13(4). 445–448.
3.
Nakamura, Masatoshi, Kayoko Ohnishi, Kensuke Nakazawa, et al.. (2023). Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases. Thoracic Cancer. 15(2). 201–205. 1 indexed citations
4.
Nakamura, Masatoshi, Kayoko Ohnishi, Hitoshi Ishikawa, et al.. (2020). Salvage Photon or Proton Radiotherapy for Oligo-recurrence in Regional Lymph Nodes After Surgery for Non-small Cell Lung Cancer. In Vivo. 34(4). 1883–1892. 5 indexed citations
5.
Nakazawa, Kensuke, Toshihiro Shiozawa, Ryoko Ogawa, et al.. (2019). Small-Cell Lung Cancer Treatment of Newly Diagnosed Patients with Poor Performance Status. Case Reports in Oncology. 12(2). 613–620. 6 indexed citations
6.
Shiozawa, Toshihiro, Ikuo Sekine, Hiroko Watanabe, et al.. (2018). Rechallenge with First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer. Case Reports in Oncology. 11(3). 622–632. 6 indexed citations
7.
Takayashiki, Norio, et al.. (2018). Chronic expanding hematoma in the chest: A case report. Experimental and Therapeutic Medicine. 15(6). 5457–5460. 5 indexed citations
8.
Kiwamoto, Takumi, Shinsuke Homma, Toshihiro Shiozawa, et al.. (2017). Paraneoplastic limbic encephalitis with late‑onset magnetic resonance imaging findings: A case report. Molecular and Clinical Oncology. 7(2). 259–262.
9.
Morishima, Yuko, et al.. (2016). Afatinib-Induced Severe Interstitial Lung Disease Successfully Treated with High-Dose Corticosteroid Therapy: A Case Report. Journal of Thoracic Oncology. 12(2). e11–e13. 3 indexed citations
10.
Tamura, Tomohiro, Koichi Kurishima, Kensuke Nakazawa, et al.. (2015). Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer. Oncology Letters. 10(2). 1135–1140. 5 indexed citations
11.
Ogawa, Ryoko, Hiroko Watanabe, Kensuke Nakazawa, et al.. (2015). Lung cancer with spontaneous regression of primary and metastatic sites: A case report. Oncology Letters. 10(1). 550–552. 12 indexed citations
12.
Tamura, Tomohiro, Koichi Kurishima, Kensuke Nakazawa, et al.. (2014). Specific organ metastases and survival in metastatic non-small-cell lung cancer. Molecular and Clinical Oncology. 3(1). 217–221. 237 indexed citations
13.
Satoh, Hiroaki, Katsunori Kagohashi, Gen Ohara, et al.. (2013). Use of tiotropium in patients with COPD aged 80 years and older. Experimental and Therapeutic Medicine. 5(4). 997–1000. 8 indexed citations
14.
Nakazawa, Kensuke, et al.. (2013). Purulent Pericarditis with Concurrent Detection of <i>Streptococcus pneumoniae</i> and Malignant Squamous Cells in Pericardial Fluid. Internal Medicine. 52(12). 1413–1416. 3 indexed citations
15.
Ho, Yuh‐Shan, Kensuke Nakazawa, Shinya Sato, et al.. (2012). Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded. Oncology Letters. 5(2). 684–688. 6 indexed citations
16.
Tamura, Tomohiro, Kensuke Nakazawa, Katsunori Kagohashi, Koichi Kurishima, & Hiroaki Satoh. (2012). Cavitary Pulmonary Metastases of Pancreas Cancer. Journal of Gastrointestinal Cancer. 44(2). 222–224. 1 indexed citations
17.
Nakazawa, Kensuke, Koichi Kurishima, Tomohiro Tamura, et al.. (2012). Specific organ metastases and survival in small cell lung cancer. Oncology Letters. 4(4). 617–620. 114 indexed citations
18.
Ohara, Gen, Kensuke Nakazawa, Tomohiro Tamura, et al.. (2012). Chemotherapy-induced complications in patients with lung cancer: An evaluation by pharmacists. Molecular and Clinical Oncology. 1(1). 65–68. 12 indexed citations
19.
Ohara, Gen, Koichi Kurishima, Kensuke Nakazawa, et al.. (2012). Age-dependent decline in renal function in patients with lung cancer. Oncology Letters. 4(1). 38–42. 8 indexed citations
20.
Muto, Hideharu, Kunihiro Yamagata, Mariko Inoue, et al.. (2005). Acute Multifocal Bacterial Nephritis Complicated with Acute Renal Failure and Thrombocytopenia. Internal Medicine. 44(10). 1084–1087. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026